Verrica Pharmaceuticals Inc (VRCA)
8.95
-0.20
(-2.19%)
USD |
NASDAQ |
May 17, 13:31
Verrica Pharmaceuticals Profit Margin (Quarterly): -531.4% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -531.4% |
| December 31, 2023 | -1.24K% |
| September 30, 2023 | -850.3% |
| June 30, 2023 | -6.04K% |
| March 31, 2023 | -17.81K% |
| December 31, 2022 | -8.72K% |
| September 30, 2022 | 1.00% |
| Date | Value |
|---|---|
| June 30, 2022 | -4.75K% |
| March 31, 2022 | -1.97K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -7.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.81K%
Minimum
Mar 2023
1.00%
Maximum
Sep 2022
-4.19K%
Average
-1.60K%
Median
Profit Margin (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -106.4% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -219.6% |
| Return on Assets | -107.4% |
| Return on Invested Capital | -129.4% |
| Gross Profit Margin (Quarterly) | 70.26% |
| Operating Margin (Quarterly) | -486.1% |
| Return on Net Operating Assets | -933.1% |